Health ❯ Healthcare ❯ Infectious Diseases

COVID-19

Variants Long COVID Statistics SARS-CoV-2 Vaccine Efficacy Virus Variants SARS-CoV-2 Variants Vaccine Development Gain-of-Function Research Public Health

FDA Approves Xocova as First Oral Post-Exposure COVID-19 Prophylaxis

Clinical trial data show a 67% cut in symptomatic infections when the five-day pill course is started within 72 hours of exposure.

Okinawa Confirms First Measles Case of 2026

Fukuoka Updates Searchable List of Flu-Related School Class Closures

EMA Backs First Combined COVID–Flu Vaccine for People 50 and Over

Long COVID Linked to Enlarged, Underperfused Choroid Plexus and Alzheimer’s Biomarkers

Early Metformin Use Tied to Lower Long COVID Risk, New Commentary Finds

Influenza Declines in Saga as Apple Disease Alert Is Lifted After 22 Weeks

COVID Shots in Pregnancy Linked to Lower Severe Illness and Preterm Birth, JAMA Study Finds

Trump Jokes About COVID After RFK Jr. Coughs at Oval Office Pfizer Event

States Step In on Vaccine Guidance as CDC Chief Considers ACIP’s September Changes

States Broaden Access to Updated COVID-19 Shots as Federal Limits Create Patchwork

Azelastine Nasal Spray Cut COVID-19 Infections in Phase 2 Trial

GSK Secures $370 Million After CureVac US Patent Settlement

Larazotide Confirms Safety and Efficacy in MIS-C, Prompts Long COVID Trial

India’s Covid-19 Caseload Falls to 5,600 as New Omicron Sub-Variants Spread

Nimbus Covid Variant Causes ‘Razor Blade’ Throat as It Becomes Second-Most Common U.S. Strain

Nimbus Covid Variant NB.1.8.1 Accelerates Globally as UK Confirms 13 Cases

US Stops Recommending COVID-19 Shots for Healthy Kids and Pregnant Women

Gurugram Records 23 COVID-19 Cases in First Surge in Two and a Half Years

Original COVID-19 Vaccine Sustains Broad Protection Against Delta and Omicron